Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/4/25 16:05 | 4/2/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Cho Dennis | CA | O | See Rema | 6 | S | -92 | 44.97 | 0 | -2 | 112 | D | |||||||||||||||
4/4/25 16:05 | 4/2/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Finn Patrick John | CA | O | P,COO | 4 | S | -351 | 48.02 | 0 | -7 | 272 | D | |||||||||||||||
4/4/25 16:05 | 4/2/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Green Paula | CA | O | SVP of H | 5 | S | -145 | 44.81 | 0 | -3 | 132 | D | |||||||||||||||
4/4/25 16:05 | 4/2/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Leproust Emily M. | CA | DO | CEO | 5 | S.d | -569 | 45.13 | 0 | -13 | 667 | D | |||||||||||||||
3/10/25 16:05 | 3/6/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Werner Robert F. | CA | O | Chief Ac | 3 | S.m | -69 | 42.88 | 0 | -2 | 53 | D | |||||||||||||||
2/25/25 16:05 | 2/21/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Laponis Adam | CA | O | CFO | 1 | S | -41 | 44.18 | 0 | -1 | 109 | D | |||||||||||||||
2/11/25 16:05 | 2/7/25 | TWST | Health | BioPrd | Biological Products, (No Diag | Chess Robert | CA | D | 1 | S | -156 | 53.14 | 0 | -3 | 61 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |